hydrastine has been researched along with Invasiveness, Neoplasm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, M; Feng, Y; Guo, B; Guo, J; Hao, C; Li, F; Li, R; Li, X; Lin, B; Liu, T; Song, S; Wang, J; Zhang, Q; Zhang, Z; Zhao, D | 1 |
Chen, M; Cheng, M; Guo, B; Li, F; Li, X; Song, S; Zhao, D | 1 |
2 other study(ies) available for hydrastine and Invasiveness, Neoplasm
Article | Year |
---|---|
Design, synthesis and biological evaluation of 1-phenanthryl-tetrahydroisoquinoline derivatives as novel p21-activated kinase 4 (PAK4) inhibitors.
Topics: Apoptosis; Benzylisoquinolines; Breast Neoplasms; Cell Cycle; Cell Movement; Cell Proliferation; Drug Design; Female; Humans; Indicators and Reagents; Lentivirus; MCF-7 Cells; Models, Molecular; Neoplasm Invasiveness; Noscapine; p21-Activated Kinases; Phenanthrenes; Protein Kinase Inhibitors; Tetrahydroisoquinolines | 2015 |
(-)-β-hydrastine suppresses the proliferation and invasion of human lung adenocarcinoma cells by inhibiting PAK4 kinase activity.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Benzylisoquinolines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neoplasm Invasiveness; p21-Activated Kinases | 2016 |